The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Seasonality of child abuse a myth

June 21, 2010 1:38 pm | by EurekAlert | News | Comments

(Indiana University School of Medicine) A new study of homicides of 797 children younger than age five has found that these deaths occur uniformly throughout the year, dispelling the widely held anecdotal notion that the winter months, and especially winter holidays, are a time of...


More than skin deep, tanning product of sun's rays

June 21, 2010 1:38 pm | by EurekAlert | News | Comments

(Penn State) People who remain pale and never tan can blame their distant ancestors for choosing to live in the northern reaches of the globe and those who easily achieve a deep tan can thank their ancestors for living in the subtropical latitudes, according to Penn State anthropologists.


Federal Register: Authorization of Emergency Use of Certain In Vitro Diagnostic Devices; Availability

June 21, 2010 1:37 pm | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing the issuance of seven Emergency Use Authorizations (EUAs) (the Authorizations), two of which were amended after initial issuance, for certain in vitro diagnostic devices.


PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution

June 21, 2010 1:34 pm | by Bio-Medicine.Org | News | Comments

MONTEREY, Calif. , June 21 /- In a head-to-head, Phase III clinical trial of Cayston delivered by the Altera Nebulizer System versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa , the co-primary endpoint of non-inferiority for mean percent change...


Mylotarg (gemtuzumab ozogamicin): Market Withdrawal

June 21, 2010 1:31 pm | by U.S. Food & Drug Administration | News | Comments

Drug failed to demonstrate clinical benefit to patients enrolled in trials.


Moody's lifts several ratings for McKesson

June 21, 2010 12:45 pm | by The Associated Press | News | Comments

Moody's Investors Services on Monday raised several ratings for McKesson Corp., citing the drug distributor's improved operating margins and the company's conservative stance toward its finances and acquisitions.The ratings agency upgraded McKesson's senior unsecured notes and its backed...

Canadian earnings declared Monday: Vigil Health Solutions widens year-end loss

June 21, 2010 11:45 am | by The Associated Press | News | Comments

Canadian earnings declared Monday as of 3 p.m. ET:Vigil Health Solutions Inc. (TSXV:VGL): Year end March 31, 2010, net loss $531,631, net loss $0.005 a share; 2009, net loss $388,940, net loss $0.004 a share. Revenue: 2010, $4,100,000; 2009, $4,500,000.

Medical device lobby spent $385K on lobbying in 1Q

June 21, 2010 10:45 am | by The Associated Press | News | Comments

The medical device industry's chief advocacy group spent more than $385,000 lobbying Congress in the first three months of 2010, as lawmakers finalized the health care overhaul.The group lobbied on the health care bill passed into law in March, which calls on medical device makers to pay...


NTU ramps up collaboration with Israel's top university

June 21, 2010 10:37 am | by EurekAlert | News | Comments

(Nanyang Technological University) Singapore's leading science and technology university, NTU and Israel's number one university, Technion-Israel Institute of Technology, announced a new collaboration to jointly offer a Doctor of Philosophy program and to increase the level of...


Stryker Declares a $0.15 Per Share Quarterly Dividend

June 21, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich. , June 21 /- Stryker Corporation (NYSE: SYK ) announced today that its Board of Directors has declared a quarterly dividend of $0.15 per share payable on July 30, 2010 to shareholders of record at the close of business on June 30, 2010 .     Stryker is one of...


Former Medtronic executive gets top spot at Colorado spine firm

June 21, 2010 10:36 am | by Mass Device | News | Comments

Medtronic Inc.'s former chief operating officer Michael DeMane joins spinal surgery device company Lanx Inc. as chairman and CEO. By Thomas Lee Michael DeMane joined Lanx Inc. as chairman and CEO. The former chief operating officer at Medtronic Inc. (NYSE:MDT) was once...


HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference

June 21, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS , June 21 /- HeartSine Technologies Ltd. recently joined 29 other companies on the 2010 Index 30, an annually compiled list of the most exciting companies with operations in the U.S. and Ireland . Other companies on this year's Index 30 list, compiled by The Irish Echo , the...


Vigil Health Q4 loss balloons as revenue drops

June 21, 2010 9:45 am | by The Associated Press | News | Comments

Vigil Health Solutions Inc. saw its fourth-quarter and year-end losses balloon, hit by a drop in revenues for both periods.The company (TSXV:VGN), which provides emergency call and nurse call systems for seniors, said Monday its loss for the quarter ended March 31 increased to $235,782 from a...

Public Hearing: Development of Articles for Rare Diseases, June 29-30, 2010

June 21, 2010 9:35 am | by U.S. Food & Drug Administration | News | Comments

This public hearing is intended to gain from health care providers, academia, industry, patients, and other interested persons their perspectives on various aspects of the development of medical products for the diagnosis, treatment, or management of...

How to become a salesperson of influence

June 21, 2010 9:35 am | by Mass Device | News | Comments

Ten tips to help medical device salespeople become influential advisors to their hospital and physician customers. The other day I spoke to a sales trainer, who was a reference for a candidate. He talked about the difference between being a "pleaser" and an "adviser" to customers. The...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.